A randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples